window.nastygoat = {aid:"QmpAtr2rEvP0rBE6aLr_vbMj2ipJhivzons1Kz6YwBmK",pid:"pV3wFgoS2e_p3hbV9eITadPmtqU9QNb47PkA8QwxvI4b"}; > Planning Our Family with Clearblue® Connected Ovulation Test System - Carnations & Lace
Select Page

Thank you Clearblue® for sponsoring this post. The new Clearblue® Connected Ovulation Test System is now available at major retailers across the U.S. such as Walmart, Target, Amazon and Meijer. Visit a store near you to try it!.

I am a planner. It’s the way I’ve always been. So when my family and future family are involved, I take an extra step. That’s where Clearblue® comes in to ease my OCD anxieties! When it comes to tracking a woman’s fertility, all cycles are different. The new Clearblue® Connected Ovulation Test System accurately identifies personal fertile days using her hormone data – instead of guessing from a standardized algorithm. To put it simply, the system typically identifies 4 or more fertile days per cycle.(1) No more calendars, alarms, or stress! They’ve totally changed the game when it comes to conceiving.

You might be surprised to know that a recent published study found that only 9% of free apps accurately predicted the best days for conception.(2) I don’t know about you guys, but that is not good enough for me! The new Clearblue® Connected Ovulation Test System gives women reassurance by measuring our LH and E3G hormones to identify the fertile period and remove any guesswork, thanks to the app. The system is over 99% accurate at detecting the LH surge. I like those odds!

Although we aren’t currently expecting, my husband and I know that there is a sweet angel babe waiting to join our family, and Clearblue® Connected Ovulation Test System is going to help us get them here. We trust that everything happens for a reason and when the time is right, Kai will be the best big brother! Don’t worry, you guys will be the first to know when that day comes!

xx

-Krychele

1 In a study of 87 women, 4 or more fertile days were identified in 80% of cycles using actual cycle length (2012)
2 Setton et al. Obstet Gynecol (2016) 128: 58–63.

I was selected for this opportunity as a member of CLEVER and the content and opinions expressed here are all my own.